As of 1:30 PM on the 18th, Komipharm is trading at 13,450 KRW, down 3.93% from the previous day. This represents an 18.48% decline compared to August 25. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners have net sold 47,540 shares of Komipharm, while institutions have net bought 3,000 shares, according to provisional data. Over the past five days, individual investors have net bought 80,523 shares, foreigners have net bought 13,945 shares, and institutions have net sold 104,061 shares respectively.
On September 8, Komipharm was a market issue due to the 'AIFA COVID clinical trial withdrawal news causing weakness.'
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
